Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores]"'
Autor:
J.K. Buitelaar, G.H.H. van de Loo-Neus, L. Hennissen, C.U. Greven, P.J. Hoekstra, P. Nagy, A. Ramos-Quiroga, E. Rosenthal, S. Kabir, K.K.C. Man, Wong IC, D. Coghill, Alexander Häge, Tobias Banaschewski, Sarah K. Inglis, Sara Carucci, Marina Danckaerts, Ralf W. Dittmann, Bruno Falissard, Peter Garas, Chris Hollis, Kerstin Konrad, Hanna Kovshoff, Elizabeth Liddle, Suzanne McCarthy, Antje Neubert, Edmund J.S. Sonuga-Barke, Alessandro Zuddas
Publikováno v:
European Neuropsychopharmacology, 64, 63-71. ELSEVIER SCIENCE BV
European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Scientia
European Neuropsychopharmacology, 64, pp. 63-71
European Neuropsychopharmacology, 64, 63-71
European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Scientia
European Neuropsychopharmacology, 64, pp. 63-71
European Neuropsychopharmacology, 64, 63-71
European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Published by Elsevier, Amsterdam
Published by Elsevier, Amsterdam
Autor:
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Publikováno v:
Scientia
Pevonedistat; Chronic myelomonocytic leukemia Pevonedistat; Leucemia mielomonocítica crónica Pevonedistat; Leucèmia mielomonocítica crònica PANTHER is a global, randomized phase 3 trial of pevonedistat+azacitidine (n = 227) vs azacitidine monoth
Autor:
Departament de Salut
Publikováno v:
Scientia
Calor; Persones vulnerables; Consells Calor; Personas vulnerables; Consejos Heat; Vulnerable people; Tips Aquest cartell conté recomanacions per evitar els efectes de l'excés de calor en la població vulnerable.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::bb5320c7777b3f9543bd9f24cee0d8f1
https://hdl.handle.net/11351/9748
https://hdl.handle.net/11351/9748
Autor:
Departament de Salut
Publikováno v:
Scientia
Calor elevada; Mesures de prevenció; Resultats Calor elevada; Medidas de prevención; Resultados High heat; Preventive measures; Results El Pla d'actuació per prevenir els efectes de les onades de calor sobre la salut (POCS) a Catalunya és un pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::322d5ea2f9786a8340717b14baa3d351
https://hdl.handle.net/11351/9856
https://hdl.handle.net/11351/9856
Autor:
Jaume Alijotas‐Reig, Victor García‐GImenez, Peter J. Velthuis, Frank B. Niessen, Tom S. Decates
Publikováno v:
Scientia
Journal of Cosmetic Dermatology, 21(8), 3181-3187. Wiley-Blackwell Publishing Ltd
Alijotas-Reig, J, García-GImenez, V, Velthuis, P J, Niessen, F B & Decates, T S 2022, ' Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers : A case series of 20 patients ', Journal of Cosmetic Dermatology, vol. 21, no. 8, pp. 3181-3187 . https://doi.org/10.1111/jocd.15117
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Cosmetic Dermatology, 21(8), 3181-3187. Wiley-Blackwell Publishing Ltd
Alijotas-Reig, J, García-GImenez, V, Velthuis, P J, Niessen, F B & Decates, T S 2022, ' Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers : A case series of 20 patients ', Journal of Cosmetic Dermatology, vol. 21, no. 8, pp. 3181-3187 . https://doi.org/10.1111/jocd.15117
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
COVID-19; Inflammation; Soft tissue fillers COVID-19; Inflamación; Rellenos de tejidos blandos COVID-19; Inflamació; Farciments de teixits tous Background Adverse events (AE) after COVID-19 vaccines, particularly, but not solely, with those messeng
Autor:
Laura Villa, José Antonio Boga, Luis Otero, Fernando Vazquez, Ana Milagro, Paula Salmerón, Martí Vall-Mayans, María Dolores Maciá, Samuel Bernal, Luis Piñeiro
Publikováno v:
Scientia
Antibiotics; Volume 12; Issue 6; Pages: 975
Antibiotics; Volume 12; Issue 6; Pages: 975
Chlamydia trachomatis; Sexually transmitted infection; Treatment failure Chlamydia trachomatis; Infecció de transmissió sexual; Fracàs del tractament Chlamydia trachomatis; Infección transmitida sexualmente; Fracaso del tratamiento The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d867b06892dce1328c04463b6c484bfe
https://hdl.handle.net/11351/9985
https://hdl.handle.net/11351/9985
Autor:
García Martínez, Rafael, Sanz Gea, Clara, Martin Riera, Victor, Guerra-Ruiz, Armando, Paciucci Barzanti, Rosanna, Ferrer Costa, Roser, Ramírez Serra, Clara
Publikováno v:
Scientia
Dasatinib; Pleural effusion chylothorax Dasatinib; Derrame pleural quilotórax Dasatinib; Vessament pleural quilotòrax Dasatinib is a tyrosine kinase inhibitor drug used for chronic myeloid leukaemia (CML) treatment. Chylothorax has been rarely repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::6195967669a2e1a957b9e627177d10e5
https://hdl.handle.net/11351/9488
https://hdl.handle.net/11351/9488
Autor:
Boix Alonso, Héctor, Fernandez Garcia, Cristina, Serrano Martín, María del Mar, Arruza, Luis, Concheiro-Guisan, Ana, Gimeno, Ana
Publikováno v:
Scientia
Non-invasive respiratory ventilation; Preterm infant; Respiratory distress syndrome Ventilación respiratoria no invasiva; Bebé prematuro; Síndrome de dificultad respiratoria Ventilació respiratòria no invasiva; Nadó prematur; Síndrome de dific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::b67cad6a13c67c3e2043b04facc52744
https://hdl.handle.net/11351/9276
https://hdl.handle.net/11351/9276
Autor:
James J. Harding, Sarina A. Piha-Paul, Ronak H. Shah, Jessica J. Murphy, James M. Cleary, Geoffrey I. Shapiro, David I. Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M. Ford, Mónica Arnedos, Salomon M. Stemmer, Christelle de la Fouchardiere, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S. Duygu Selcuklu, Michael F. Berger, Lisa D. Eli, Funda Meric-Bernstam, Komal Jhaveri, David B. Solit, Ghassan K. Abou-Alfa
Publikováno v:
Scientia
Antitumour activity; Neratinib; Biliary tract cancers Actividad antitumoral; Neratinib; Cánceres de vías biliares Activitat antitumoral; Neratinib; Càncers de vies biliars HER2 mutations are infrequent genomic events in biliary tract cancers (BTCs
Autor:
Nancy U. Lin, Rashmi K. Murthy, Vandana Abramson, Carey Anders, Thomas Bachelot, Philippe L. Bedard, Virginia Borges, David Cameron, Lisa A. Carey, A. Jo Chien, Giuseppe Curigliano, Michael P. DiGiovanna, Karen Gelmon, Gabriel Hortobagyi, Sara A. Hurvitz, Ian Krop, Sherene Loi, Sibylle Loibl, Volkmar Mueller, Mafalda Oliveira, Elisavet Paplomata, Mark Pegram, Dennis Slamon, Amelia Zelnak, Jorge Ramos, Wentao Feng, Eric Winer
Publikováno v:
Scientia
U. Lin, N, K. Murthy, R, Abramson, V, Anders, C, Bachelot, T, L. Bedard, P, Borges, V, Cameron, D A, A. Carey, L, Chien, J, Curigliano, G, P. Di Giovanna, M, Gelmon, K, Hortobagyi, G, A. Hurvitz, S, Krop, I, Loi, S, Loibl, S, Mueller, V, Oliveira, M, Paplomata, E, Pegram, M, Slamon, D, Zelnak, A, Ramos, J, Feng, W & Winer, E 2022, ' Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain MetastasesUpdated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2022.5610
U. Lin, N, K. Murthy, R, Abramson, V, Anders, C, Bachelot, T, L. Bedard, P, Borges, V, Cameron, D A, A. Carey, L, Chien, J, Curigliano, G, P. Di Giovanna, M, Gelmon, K, Hortobagyi, G, A. Hurvitz, S, Krop, I, Loi, S, Loibl, S, Mueller, V, Oliveira, M, Paplomata, E, Pegram, M, Slamon, D, Zelnak, A, Ramos, J, Feng, W & Winer, E 2022, ' Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain MetastasesUpdated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2022.5610
ImportanceIt is estimated that up to 50% of patients with ERBB2 (HER2)-positive metastatic breast cancer (MBC) will develop brain metastases (BMs), which is associated with poor prognosis. Previous reports of the HER2CLIMB trial have demonstrated tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f800399cc04de7baef3960b16afc0f9b
https://hdl.handle.net/11351/9527
https://hdl.handle.net/11351/9527